MAPT and Alzheimer disease: For example, detection of Aβ1 − 42 and p-tau in CSF is a well-established method in AD diagnosis (Iwatsubo et al., 1994; Motter et al., 1995; Lleo et al., 2015; Olsson et al., 2016).